4//SEC Filing
Kaplan Brett 4
Accession 0001209191-20-018123
CIK 0001714798other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:51 PM ET
Size
5.7 KB
Accession
0001209191-20-018123
Insider Transaction Report
Form 4
Kaplan Brett
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-02-19+95,000→ 95,000 totalExercise: $16.91Exp: 2030-02-19→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]25% of the total number of shares underlying the option vest and become exercisable on February 19, 2021 and an additional 1/48th of the total number of shares underlying the option shall vest and become exercisable on the same date of each of the thirty-six (36) consecutive months thereafter subject, in all cases, to the Reporting Person providing continuous service with the Issuer on each such date.
Documents
Issuer
Prevail Therapeutics Inc.
CIK 0001714798
Entity typeother
Related Parties
1- filerCIK 0001778763
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:51 PM ET
- Size
- 5.7 KB